地高辛治療窗濃度的再探討

《地高辛治療窗濃度的再探討》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。

1、地高辛治療窗濃度的再探討1*11123司凱英,王守春,欒杰,高志剛,韓麗萍,肖艷(11黑龍江大慶龍南醫(yī)院,大慶市163453;21廣州軍區(qū)廣州總醫(yī)院,廣州市510010;31黑龍江大慶油田總醫(yī)院,大慶市163000)+中圖分類號(hào)R96913;R97211文獻(xiàn)標(biāo)識(shí)碼A文章編號(hào)1001-0408(2005)14-1081-03摘要目的:探討地高辛治療慢性心力衰竭的血清治療窗濃度范圍。方法:將心力衰竭患者隨機(jī)分成小劑量組和常規(guī)劑量組,分別給予小劑量和常規(guī)劑量地高辛治療,采用熒光偏振免疫法測(cè)定地高辛血藥濃度。結(jié)果:小劑量組有效率、無效率、中毒率分別為7119%、2119%

2、、613%,常規(guī)劑量組分別為6417%、1911%、1612%,2組有效率、無效率均無顯著性差異(P>0105),中毒率小劑量組顯著低于常規(guī)劑量組(P<0105);小劑量組地高辛有效、無效、中毒濃度分別為(0187±0141)、(0167±0134)、(1170±0148)μg/L,常規(guī)劑量組分別為(1111±0148)、(0171±0139)、(1169±0163)μg/L,2組地高辛無效濃度、中毒濃度均無顯著性差異(P>0105),地高辛有效濃度小劑量組顯著低于常規(guī)劑量組(P<0101)。結(jié)論:地高辛治療慢性心力衰竭的血清治療窗濃度范圍以0150～1150μg

3、/L為宜。關(guān)鍵詞地高辛;心力衰竭;藥物監(jiān)測(cè);治療窗DiscussiononTherapeuticWindowConcentrationofDigoxinSIKaiying,WANGShouchun,LUANJie,GAOZhigang(DaqingLongnanHospitalofHeilongjiangProvince,Daqing163453,China)HANLiping(GuangzhouGeneralHospital,GuangzhouMilitaryCommand,Guangzhou510010,China)XIAOYan(DaqingOilField

4、GeneralHospital,Daqing163000,China)ABSTRACTOBJECTIVE:Tostudythetherapeuticwindowconcentrationrangeofserumdigoxininthetreatmentofchroniccardiacfailure1METHODS:Patientswithchroniccardiacfailureweredividedintosmalldosegroupandroutinedosegroup,andadministeredrespectivelywithlowdosedigoxin

5、androutinedosedigoxin,theserumdigoxinconcentrationsinpa2tientsweredeterminedbyFPIA1RESULTS:Theeffectiverate,invalidrateandtoxicationratesofthelowdosedigoxingroupwere7119%,2119%and613%respectively,thosefortheroutinedosedigoxingroupwere6417%,1911%and1612%re2spectively,nosignificantdiffe

6、renceswerefoundineffectiveratesandtheinvalidratesbetween2groups(P>0105),thetoxi2cationrateofthelowdosegroupwaslowerthanthatoftheroutinegroup(P<0105);Theeffectiveconcentrationrange,invalidconcentrationrangeandthetoxicconcentrationrangeoflowdosedigoxingroupwere(0187±0141),(0167±0134)and

7、(1170±0148)μg/Lrespectively,andthosefortheroutinegroupwere(1111±0148),(0171±0139)and(1169±0163)μg/Lrespec2tively,nosignificantdifferenceswerefoundintheinvalidconcentrationandthetoxicationconcentrationbetweenthetwogroups(P>0105),theeffectiveconcentrationofthelowdosedigoxingroupwassigni

8、fican